1. Home
  2. News Archive

More News

ESCRS Congress Becomes Biggest International Ophthalmic Meeting
ESCRS Congress Becomes Biggest International Ophthalmic Meeting
The 2026 congress of the European Society of Cataract and Refractive Surgeons (ESCRS) drew 17,717 attendees from more than 142 countries to London in the UK, setting a new record and making the con...
2026-2027 Ophthalmic Meetings Calendar
2026-2027 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
ESCRS iNovation Day Spotlights Tech Boom and Barriers to Adoption
ESCRS iNovation Day Spotlights Tech Boom and Barriers to Adoption
ESCRS iNovation Day showcased a broad pipeline of ophthalmic technologies, but companies expressed concerns over the economic climate. The forum was held Sept. 11, ahead of the ESCRS program in Lon...
Excimer Laser Celebration Marks 40 Years of Refractive Surgery Innovation
Excimer Laser Celebration Marks 40 Years of Refractive Surgery Innovation
The 2026 ESCRS congress marked 40 years of excimer laser technology in refractive surgery with its Excimer Laser Celebration. Hosted at the Excimer Laser Museum in the exhibition area, the event ho...
Norlase Presents Early PMLT Results in Glaucoma Patients at ESCRS Congress
Norlase Presents Early PMLT Results in Glaucoma Patients at ESCRS Congress
Alexander S. Thrane, MD, PhD, FEBOphth, presented initial clinical data for Norlase’s pattern microsecond laser trabeculoplasty (PMLT) treatment at the 2026 ESCRS congress, saying patients experien...
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 million in cash. AVS,...
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot (formerly Virtual Field) reported Oct. 9 that it had agreed to acquire GreenMan Vision, of West Fargo, North Dakota, and its InSightVR IOL simulator. No financial details were provided. The ...
Emerging Companies Pursuing Ophthalmic Indications, October 2026
Emerging Companies Pursuing Ophthalmic Indications, October 2026
Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.
Clinical Trial Updates for Ophthalmic Candidates, October 2026
Clinical Trial Updates for Ophthalmic Candidates, October 2026
Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.
Study Indicates that Circadian Rhythm and Light May Affect IOP
Study Indicates that Circadian Rhythm and Light May Affect IOP
Researchers at the University of South Florida (USF) reported Sept. 30 that continuously monitoring intraocular pressure (IOP) in a rat model showed that eye pressure follows a daily rhythm, consis...
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
The US FDA sent Bausch + Lomb a warning letter Sept. 4 regarding significant violations observed at its manufacturing plant in Tampa, Florida, during an FDA inspection in March 2026. The Tampa loca...
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Japan’s Nidek announced Sept. 3 the launch of three new ophthalmic diagnostic offerings. The RSD-1 Duo, a combined OCT and fundus camera system, and the AFC-1 fundus camera increase efficiency acro...
Weekly Poll of MDs, US and Western Europe, October 2026
Weekly Poll of MDs, US and Western Europe, October 2026
October 2026 Ophthalmic News Briefs
October 2026 Ophthalmic News Briefs
Sagent Pharmaceuticals, of Schaumburg, Illinois, announced Sept. 22 the US launch of Zyogreen, the first FDA-approved ready-to-use indocyanine green (ICG) injection in the US. Sagent said conventio...
US FDA Approves Genentech’s Enspryng, the First Subcutaneous Treatment for TED
US FDA Approves Genentech’s Enspryng, the First Subcutaneous Treatment for TED
Genentech and its parent, Roche, announced Oct. 16 that the US FDA had approved Enspryng (satralizumab-mwge) for the treatment of adults with thyroid eye disease (TED). It’s the first at-home, subc...
Alvotech, Advanz Submit Marketing Application to EMA for High-Dose Aflibercept Biosimilar
Alvotech, Advanz Submit Marketing Application to EMA for High-Dose Aflibercept Biosimilar
Alvotech and partner Advanz Pharma announced Oct. 14 that they had submitted a marketing authorization application to the European Medicines Agency (EMA) for AVT29, a proposed biosimilar to Eylea (...
Merck Sees Mixed Results at One Year in Pivotal Trial of Remigromig in DME
Merck Sees Mixed Results at One Year in Pivotal Trial of Remigromig in DME
Merck presented one-year results from remigromig’s pivotal Phase IIb/III BRUNELLO trial at the 2026 meeting of the American Academy of Ophthalmology (AAO), held Oct. 10-12 in New Orleans, Louisiana...
Saunders Departs Bausch + Lomb, as Chairman Appio Takes Over
Saunders Departs Bausch + Lomb, as Chairman Appio Takes Over
Bausch + Lomb announced Oct. 12 that CEO Brent Saunders would leave the company immediately, with chairman Thomas Appio taking over as interim CEO. Appio also is CEO of Bausch Health. Saunders had ...
US FDA Accepts BLA for Genentech’s Vamikibart in UME; Decision Expected by July 2027
US FDA Accepts BLA for Genentech’s Vamikibart in UME; Decision Expected by July 2027 
Genentech, a member of the Roche group, reported Oct. 10 that the US FDA had accepted the biologics license application (BLA) for vamikibart, an intravitreal IL-6 inhibitor candidate for uveitic ma...
Visara Licenses Topical Neurotrophic Keratitis Candidate from China’s Hiteck
Visara Licenses Topical Neurotrophic Keratitis Candidate from China’s Hiteck
Visara, the ophthalmic subsidiary of NovaBridge Biosciences, announced Oct. 13 that it had licensed a topical candidate targeting neurotrophic keratitis (NK) from China’s Wuhan Hiteck Biopharma. VI...
Corza Medical Launches Expanded Single-Use Custom Packs
Corza Medical Launches Expanded Single-Use Custom Packs
Corza Medical, of Boulder, Colorado, announced Oct. 10 the launch of its expanded Blink single-use custom surgical packs. The company also debuted a new automated manufacturing process for its Shar...
HelpMeSee Names Former Test Pilot Doug May as President and CEO
HelpMeSee Names Former Test Pilot Doug May as President and CEO
Global nonprofit group HelpMeSee announced Oct. 1 that it had appointed Doug May as president and chief executive officer. May joined HelpMeSee in 2025 as chief operating officer. He previously wor...
Glaukos Licenses Tri-specific Retinal Candidate RO-104 from RevOpsis
Glaukos Licenses Tri-specific Retinal Candidate RO-104 from RevOpsis
Glaukos announced Oct. 8 that it had licensed from RevOpsis Therapeutics the exclusive rights to develop and commercialize RO-104, a novel tri-specific biologic candidate targeting wet age-related ...
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot, Maker of VR Visual Field Testing, Acquires IOL Simulation Developer GreenMan
Carrot (formerly Virtual Field) reported Oct. 9 that it had agreed to acquire GreenMan Vision, of West Fargo, North Dakota, and its InSightVR IOL simulator. No financial details were provided. The ...
Sagent Launches Zyogreen Ready-to-Use Indocyanine Green Dye for Injection in the US
Sagent Launches Zyogreen Ready-to-Use Indocyanine Green Dye for Injection in the US
Sagent Pharmaceuticals, of Schaumburg, Illinois, announced Sept. 22 the US launch of Zyogreen (indocyanine green injection). Sagent said Zyogreen is the first and only FDA-approved ready-to-use ind...
Study Indicates that Circadian Rhythm and Light May Affect IOP
Study Indicates that Circadian Rhythm and Light May Affect IOP
Researchers at the University of South Florida (USF) reported Sept. 30 that continuously monitoring intraocular pressure (IOP) in a rat model showed that eye pressure follows a daily rhythm, consis...
Nobel Prize for Medicine Goes to Team First to Publish Optogenetics Findings
Nobel Prize for Medicine Goes to Team First to Publish Optogenetics Findings
Three scientists who helped develop optogenetics received the 2026 Nobel Prize in Physiology or Medicine on Oct. 5. They are Karl Deisseroth, MD, PhD, of the Howard Hughes Medical Institute in Mary...
VEO Ophthalmics to Market the VitaPixel Visualization System for Slit Lamps
VEO Ophthalmics to Market the VitaPixel Visualization System for Slit Lamps
VEO Ophthalmics and VitaPixel announced a collaboration Oct. 2 under which VEO will market the VitaPixel SVS, a stereoscopic digital visualization system for slit lamps. The VitaPixel SVS combines ...
Japanese Regulators Accept NDA for Nanoscope’s Optogenetic Gene Therapy Candidate, Grant Priority Review
Japanese Regulators Accept NDA for Nanoscope’s Optogenetic Gene Therapy Candidate, Grant Priority Review
Nanoscope Therapeutics announced Oct. 1 that regulators in Japan had accepted the company’s new drug application for Mogenry, an optogenetic gene therapy candidate targeting inherited retinal dystr...
US FDA Gives Green Light to Trial of Surrozen’s DME Candidate
US FDA Gives Green Light to Trial of Surrozen’s DME Candidate
Surrozen announced on Oct. 2 that the US FDA had signed off on its investigational new drug application, allowing the company to proceed with a clinical trial of SZN-8141, a bifunctional Wnt agonis...
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Acquires IOL Maker Advanced Vision Science for $13 Million
SpyGlass Pharma announced Oct. 1 that it had acquired all outstanding shares of common stock in Advanced Vision Science (AVS), a manufacturer of intraocular lenses and lens materials, for $13 milli...
MyEyeDr. Acquires Optometry Division of EyeCare Partners
MyEyeDr. Acquires Optometry Division of EyeCare Partners
MyEyeDr., of Vienna, Virginia, announced Sept. 28 that it would acquire the optometry division of EyeCare Partners, of St. Louis, Missouri. The deal covers the optometric brands of Clarkson Eyecare...
Aldeyra to File Formal Dispute with US FDA over Reproxalap Rejection
Aldeyra to File Formal Dispute with US FDA over Reproxalap Rejection
Aldeyra Therapeutics reported Sept. 29 that it would submit a formal dispute resolution request with the US FDA over the rejection of reproxalap, a topical treatment candidate for dry eye disease. ...
Ocugen Gains Provisional Approval in Bahamas to Treat RP Patients with OCU400
Ocugen Gains Provisional Approval in Bahamas to Treat RP Patients with OCU400
Ocugen announced Sept. 25 that OCU400, its subretinal modifier gene therapy candidate targeting retinitis pigmentosa (RP), had been granted provisional approval and priority designation by regulato...
Sightpath Medical Adds Retinal Equipment to Mobile Offering
Sightpath Medical Adds Retinal Equipment to Mobile Offering
Sightpath Medical reported Sept. 22 that it now delivers retinal equipment for ophthalmic surgery. The company’s mobile services for retina specialists include delivery of a vitrectomy platform in ...
iRegene’s RP Cell Therapy Candidate Gets Green Light for Clinical Trials in China, US
iRegene’s RP Cell Therapy Candidate Gets Green Light for Clinical Trials in China, US
China’s iRegene Therapeutics announced Sept. 29 that its cell therapy candidate targeting retinitis pigmentosa (RP) gained authorization from regulators to enter clinical trials in both China and t...
InSightVR IOL Simulator Linked to Increased Premium Lens Selection, Better Understanding
InSightVR IOL Simulator Linked to Increased Premium Lens Selection, Better Understanding
GreenMan Vision, of West Fargo, North Dakota, reported Sept. 21 that its InSightVR IOL simulator was associated with several key benefits in a study published Sept. 5 in the journal Patient Prefere...
Claris Bio Establishes Corporate Headquarters in San Francisco
Claris Bio Establishes Corporate Headquarters in San Francisco
Claris Bio reported Sept. 24 that it had moved its corporate headquarters from Jersey City, New Jersey, to San Francisco, California. Its new home is at 701 Gateway Blvd., Suite 250, South San Fran...
FDA Panel Meeting for Sydnexis’ Rejected Myopia Drop Candidate Set for Oct. 30
FDA Panel Meeting for Sydnexis’ Rejected Myopia Drop Candidate Set for Oct. 30
Sydnexis reported Sept. 24 that the US FDA had set Oct. 30 as the date for an advisory committee and open public hearing to review the new drug application (NDA) for SYD-101, an atropine eye drop c...
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
Rayner Launches RayOne Galaxy IOL in US after Receiving FDA Approval
UK-based Rayner announced Sept. 24 that its RayOne Galaxy and RayOne Galaxy Toric IOLs were commercially available in the US after the lenses gained FDA approval. The company noted that US surgeons...
Roche Gains EU Approval for Susvimo Sustained-Release Wet AMD Treatment
Roche Gains EU Approval for Susvimo Sustained-Release Wet AMD Treatment
Swiss drugmaker Roche announced Sept. 21 that the European Commission had granted marketing authorization for Susvimo (ranibizumab injection) 100 mg/mL for the treatment of wet age-related macular ...
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Future of Ophthalmic Diagnostic Innovation May Hinge on Integration, Reliability
Manufacturers have invested heavily in AI, cloud connectivity, and digital applications over the past several years. These developments are continuing, but AI and digitalization are becoming less d...
Zeiss Introduces Alta Duo 300, a Fully Automated OCT Combination Retinal Imager
Zeiss Introduces Alta Duo 300, a Fully Automated OCT Combination Retinal Imager
Zeiss Medical Technology reported Sept. 17 that it had introduced the Alta Duo 300 combination retinal imager. The device will be available in select markets later in 2026. The German company said ...
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Combination OCT-Fundus Camera Headlines Product Launches from Nidek
Japan’s Nidek announced Sept. 3 the launch of three new ophthalmic diagnostic offerings. The RSD-1 Duo, a combined OCT and fundus camera system, and the AFC-1 fundus camera increase efficiency acro...
UK Pet Food Company Concludes Recall After Reports of Sudden Dry Eye Symptoms in Dogs
UK Pet Food Company Concludes Recall After Reports of Sudden Dry Eye Symptoms in Dogs
The Years pet food company, based in the UK, has concluded a recall of all its fresh pet food products after an independent investigation found no link between its ingredients and dog owners’ repor...
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
Bausch + Lomb Receives FDA Warning Letter for Tampa, Florida, Plant, Citing Persistent Contamination
The US FDA sent Bausch + Lomb a warning letter Sept. 4 regarding significant violations observed at its manufacturing plant in Tampa, Florida, during an FDA inspection in March 2026. The Tampa loca...
€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel
€1 Million Champalimaud Vision Award in 2026 Goes to Botond Roska and José-Alain Sahel
The winners of the 2026 António Champalimaud Vision Award are researchers Botond Roska, MD, PhD, of Switzerland, and José-Alain Sahel, MD, of France and the US, for their pioneering optogenetic the...
Norlase Establishes Direct Commercial Presence in the United Kingdom
Norlase Establishes Direct Commercial Presence in the United Kingdom
Norlase announced on Sept. 8 that it had expanded its footprint in Europe with a direct commercial presence in the United Kingdom. The Danish company, with US offices in Redwood City, California, a...
Chinese Regulators Accept NDA for Low-Dose Atropine Drop for Myopia from Santen
Chinese Regulators Accept NDA for Low-Dose Atropine Drop for Myopia from Santen
Japan’s Santen announced Sept. 14 that China’s National Medical Products Administration (NMPA) had accepted the new drug application (NDA) for STN1012700 (atropine sulfate ophthalmic solution 0.025...
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
Ophthalmologists Report 5.4 Percent Decrease in Q2-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 5.4 percent in Q2-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...

Want to Read Locked Articles?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.